Breadcrumb

CME Submission Page

Submission Form

Input style

Please follow this general style:

Name of Event
This should be the type of the event along with the subject and speaker. It does not need to be the full title. The full title can appear in the description section.

For example: Grand Rounds: Dr. Jami Woods, "Beyond dopamine, part one."

Location
For in-person locations, you should list the location site and room number. Try to avoid using abbreviations or acronyms.

Start date
This is the date of the event. Multiple-day events must be submitted with a separate entry for each day.

Start and End time
The time your event begins and ends.

Web Link
If this is an in-person event, this would be a link to your in-person RSVP (e.g., Eventbrite or similar).

If this is an online event, this should be a link to your Zoom or other online meeting.

Important: You should NEVER post a direct link to your meeting. Please make sure to use the registration function on Zoom. This will lessen the likelihood of your meeting being disrupted.

Description

The description should contain the bulk of your meeting content. The first line should be the type of event and the long title, with the name of the speaker below. For example:


Grand Rounds: “Beyond dopamine, part one. The convergence of glutamate and dopamine in the pathogenesis and treatment of schizophrenia"

Presenter: Jami Woods, D.Ph., M.D., A.B.P.N., A.S.C.P.
Assistant Professor of Psychiatry & Vice Chair Diversity and Inclusion
Department of Psychiatry and Neuroscience, University of California, Riverside School of Medicine

Learning Objectives: At the end of the presentation the attendees will be able to:

  • Explain dopamine dysregulation hypothesis of schizophrenia.
  • Describe the role that abnormally hypofunctioning NMDA glutamate receptors play in driving dopamine dysregulation.
  • Identify key differences between dopamine antagonists and partial agonists.
  • Apply new treatment options for schizophrenia that do not rely solely on D2 receptor occupancy for efficacy.

Credit: Approved for 1 AMA PRA Category 1 Credit

Contact: ::email address of person who can answer questions.::